These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3660340)

  • 21. Thrombin activity of fibrin thrombi and soluble plasmic derivatives.
    Francis CW; Markham RE; Barlow GH; Florack TM; Dobrzynski DM; Marder VJ
    J Lab Clin Med; 1983 Aug; 102(2):220-30. PubMed ID: 6223106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of fibrin polymerization by fragment d is affected by calcium, Gly-Pro-Arg and Gly-His-Arg.
    Furlan M; Rupp C; Beck EA
    Biochim Biophys Acta; 1983 Jan; 742(1):25-32. PubMed ID: 6824684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of glycosaminoglycans on thrombin- and atroxin-induced fibrin assembly and structure.
    Carr ME; Powers PL
    Thromb Haemost; 1989 Dec; 62(4):1057-61. PubMed ID: 2559486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simulating fibrin clotting time.
    Marx G
    Med Biol Eng Comput; 2006 Mar; 44(1-2):79-85. PubMed ID: 16929924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clotting of bovine fibrinogen. Calcium binding to fibrin during clotting and its dependence on release of fibrinopeptide B.
    Mihalyi E
    Biochemistry; 1988 Feb; 27(3):967-76. PubMed ID: 3365373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 28. Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release.
    Lane DA; Cuddigan B; VanRoss M; Kakkar VV
    Br J Haematol; 1980 Mar; 44(3):483-94. PubMed ID: 6769460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
    Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
    Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure of fibrinogen and thrombin to nitric oxide donor ProliNONOate affects fibrin clot properties.
    Helms CC; Kapadia S; Gilmore AC; Lu Z; Basu S; Kim-Shapiro DB
    Blood Coagul Fibrinolysis; 2017 Jul; 28(5):356-364. PubMed ID: 27755019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha-Thrombin within fibrin clots: inactivation of thrombin by antithrombin-III.
    Naski MC; Shafer JA
    Thromb Res; 1993 Mar; 69(5):453-65. PubMed ID: 8497860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetic study on the initial stage of the fibrinogen-fibrin conversion by thrombin. (1) Application of mathematical treatment to turbidimetrical method.
    Sato H; Nakajima A
    Thromb Res; 1984 Mar; 33(6):645-51. PubMed ID: 6719406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide.
    Pretorius E; Mbotwe S; Bester J; Robinson CJ; Kell DB
    J R Soc Interface; 2016 Sep; 13(122):. PubMed ID: 27605168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibrinogen and fibrin interaction with concanavalin A dimer and its influence on coagulation.
    Díaz-Mauriño T; Blanco R; Albert A
    Biochim Biophys Acta; 1984 May; 799(1):45-50. PubMed ID: 6722179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation.
    Standeven KF; Ariëns RA; Whitaker P; Ashcroft AE; Weisel JW; Grant PJ
    Diabetes; 2002 Jan; 51(1):189-97. PubMed ID: 11756340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assays of fibrin network properties altered by VKAs in atrial fibrillation - importance of using an appropriate coagulation trigger.
    Ząbczyk M; Blombäck M; Majewski J; Karkowski G; Wallen HN; Undas A; He S
    Thromb Haemost; 2015 Apr; 113(4):851-61. PubMed ID: 25518887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble fibrin-fibrinogen complexes as intermediates in fibrin gel formation.
    Wilf J; Minton AP
    Biochemistry; 1986 Jun; 25(11):3124-33. PubMed ID: 3730352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The conversion of fibrinogen to fibrin. XIII. Dissolution of fibrin and inhibition of clotting by various neutral salts.
    SHULMAN S; KATZ S; FERRY JD
    J Gen Physiol; 1953 Jul; 36(6):759-66. PubMed ID: 13069679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of temperature on dynamic viscoelasticity during the clotting reaction of fibrin.
    Kaibara M; Fukada E
    Biochim Biophys Acta; 1977 Oct; 499(3):352-61. PubMed ID: 562194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.